Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, ...

The Joy Evans Therapeutic Recreation Center, a $40.4 million project, opened Dec. 23 in Ward 7. The 37,000-square-foot facility was developed to provide Washingtonians of all ages and abilities with ...

Misalignment between U.S. disease burden and novel therapy innovation may contribute to an increase in U.S. disease prevalence, morbidity, and premature mortality, and may exacerbate existing health ...

Since the FDA first approved CAR-T cell therapy in 2017, eight CAR-T drugs have emerged, six of which have been fully approved by the FDA. This groundbreaking cell therapy has brought about a series ...

With the global prevalence of diabetes continuing to rise, the value of scientific research and advanced therapeutic development has become increasingly evident. Diabetes is a chronic metabolic ...